Banca Akros on Friday upgraded Italian semiconductors and microelectronics company Technoprobe (TPRO.MI) to accumulate from neutral and raised its price target to 26 euros from 18 euros.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
Aardvark Therapeutics (AARD) has an average rating of overweight and mean price target of $18.45, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
TD Securities lowered its price target on AtkinsRealis Group Inc. (ATRL.TO) to $117 from $127 on Friday.Analyst Michael Tupholme maintained a Buy rating on shares of the Canadian engineering services and nuclear company following its Q1 results."We see an H2/26 nuclear tech. decision in Ontario as a re-rating catalyst," Tupholme said in a note to clients."Also, we believe the 2026 Nuclear revenue guide could be conservative, given Q1/26 growth of +37% y/y vs. vs. FY2026 guide of +9% y/y," the analyst said. "ESR org. growth is strong and FY2026 ESR margin expansion remains intact."Tupholme said the price target reduction is due to a "reduced ESR target multiple of 11.0x (was 12.5x), reflecting lower sector valuations."